Should DeSci return to value or chase memes? At the crossroads, should we go left or right?
Starting from the business models and development directions of Bio Protocol and Pump.Science, explore what the true needs of DeSci are.
Author: Kevin, the Researcher from BlockBooster
On November 26, Paul Kohlhaas, the founder of BIO Protocol, responded to CZ's tweet on social media, stating, "Decentralized Science (DeSci) has successfully brought the liquidity of Meme coins into universities and laboratories around the world, supporting genuine scientific research." This phenomenon raises questions: Why has scientific research, which is typically characterized by rigor and long-term investment, especially in the field of medicine, been able to successfully integrate with the rapidly changing cryptocurrency market?
Scientific research, especially in medicine, objectively requires a significant amount of time, often measured in years or decades, which stands in stark contrast to the current market's pursuit of "one-day quick returns." Why did decentralized science spark market discussions in November? Was it due to Meme sentiment reaching an all-time high, leading to market corrections? Or is decentralized science merely a new Meme trend disguised as scientific research benefiting humanity? This article will explore the true needs of DeSci from the business models and development directions of Bio Protocol and Pump.Science; under what circumstances can it align with market demands and achieve long-term development.
Breakdown of Bio Protocol's Business Model
First, the narrative of DeSci is triggered by Bio Protocol. On November 8, Binance completed a strategic financing round for BIO, although the round and amount were not disclosed. In response, the BIO Genesis community fundraising campaign raised $33 million.
BIO currently has seven active DAOs, focusing on research areas such as longevity, hair loss treatment, and brain health. It is important to note that BioDAO does not refer to a specific research team in a particular direction, such as the longevity health track, but should be seen as a concrete implementation of BIO Protocol. Why do I say this? Please refer to the above diagram of the BIO Protocol business model. In simple terms, BIO is a nested Launchpad, combined with non-yield staking, incentives, and an embedded Launchpad for infinite splitting. BIO consists of these four parts.
Specifically, the first part, Launchpad BioDAOs, raises funds through token sales and uses those funds to support related biotechnology projects. Each BioDAO can also be seen as a Launchpad, which I will discuss further in the fourth part.
The second part is BIO's staking mechanism, which locks user tokens under the guise of curation. From the governance and proposal pages, it can be seen that the usual staking rate for BIO is around 15%, while the staking rate when voting for new BioDAOs exceeds 20%. Users do not earn yields from staking; instead, when the BioDAO they voted for wins, they receive BIO token rewards. If the voted BioDAO is not selected, there are no rewards. Curation is a very effective tool for locking user tokens; when new BioDAOs emerge, its value output for the BIO ecosystem will far exceed the rewards distributed by BIO.
The third part is the primary use case of the BIO token, which is incentives. Incentives are divided into two parts: the first part is for participating BioDAOs, which receive incentives when they initiate their initial token sales. For users, incentives are awarded when they use BioDAO products or contribute to BioDAO; I believe the current amount of incentive tokens is minimal, and compared to the traditional scientific research industry, costs are significantly reduced, as participating in drug trials in the traditional industry is very expensive, while BIO distributes BIO token incentives.
The fourth part is the splitting mechanism. BioDAOs can be seen as sub-Launchpads, where BioDAOs choose specific teams or research topics, raise funds, and issue IP tokens or IP NFTs. Holders of these assets are promised some early participation rights but are not guaranteed any form of additional returns.
From a business model perspective, BIO still operates in a familiar manner within the industry, but its characteristic lies in the nested Launchpad structure. As specific research projects issue tokens or release NFT assets, potential liquidity issues will first impact BioDAO tokens, while the BIO token acts as a layer of insurance. The value of BIO tokens will only be questioned when multiple BioDAO tokens encounter problems, but the benefits of specific research projects releasing assets will fully feedback to BIO, as it will attract more users to buy BIO tokens and participate in the ecosystem. Another characteristic is that it encourages users to stake tokens under the pretext of participating in scientific research without having to pay yields, thus the potential returns are provided by BioDAO tokens or specific research projects, allowing BIO to lock user tokens at a very low cost over the long term. BIO is an index token across all these DAO tokens.
How Does Pump.Science Blur the Boundaries Between DeSci and Memecoin?
Molecule is a protocol that puts IP on-chain, issuing IP-NFTs and IPT for Bio Protocol; Pump.Science is Molecule's Launchpad, representing the intellectual property of certain compounds in token form.
Pump.Science believes that compared to buying stock in a biotechnology company, which indirectly means holding all of the company's drugs, on Pump.Science, one can choose to invest in a single drug. The tokens issued on Pump.Science comply with legal regulations, but from the perspective of tokenizable intellectual property, they must be artificially synthesized compounds and cannot be naturally occurring substances like nicotine. However, if nicotine is combined with other substances, such as caffeine, this combination can be patented. What Pump.Science does is tokenize these patents or data and then test their effectiveness.
Pump.Science has launched two tokens, $RIF and $URO, with $RIF reaching a market cap of $100 million. The compounds behind these tokens can be used to develop supplements and can potentially generate profits through sales or patent licensing in the future. To attract more investors, Molecule will develop a set of data to prove the effectiveness of these compounds, such as significantly extending lifespan in animal tests.
But does Pump.Science really want to do scientific research properly? It seems that this possibility is diminishing. As Christmas approaches, Pump.Science will hold a 'Rif Christmas' event, launching two tokens each day for ten days. In December, Pump.Science will intensively release 20 tokens for artificially synthesized compounds. Although the platform claims it will gradually showcase their development paths, ultimately hoping to advance to human testing stages and even develop into a product market selling different supplements, it is foreseeable that the vast majority of the 20 tokens will not sustain until the corresponding supplements hit the market and will have a market cap of zero.
From the perspective of chasing market trends, Pump.Science is also actively promoting AI-related product development. It plans to create an AI robot that trades based on compound experimental data, executing operations based on the progress of events at different stages.
Returning to the theme of this article, does DeSci need to return to value or chase Memes? From the business models and development directions of Bio Protocol and Pump.Science, it is clear that neither has fully chosen to invest in scientific research while forgoing the opportunity to provide Memecoins to the market, which may also be one of the future paths for DeSci protocols. However, one point should be clearly recognized: scientific research needs to return to fundamentals and objective laws. Biological scientific research requires long-term and substantial funding; therefore, the short-term speculation of Memecoins will not last long, and a single Memecoin is not the development model for DeSci protocols. Buying DeSci tokens requires enduring a narrative that goes unnoticed; DeSci needs to hype its valuation in the manner of VC tokens, enhance the value expectations of leading projects, and continuously release signals through totemic figures, as the market perception of DeSci is far below that of AI, necessitating more authoritative signals to increase market confidence and consensus. From the specific GTM approach, the segmented tracks of DeSci include: financing, research, data, peer review, publishing, infrastructure and services, art, scientific open ecology, and community, from which one can choose directions that align with their understanding or have relatively low implementation thresholds. Furthermore, the DeSci model is inherently a splitting mechanism; different research topics represent sub-tokens, requiring large vehicles to pull smaller ones, using web3 financing to obtain a crowdfunding-like approach to fund a specific research project in reality, making it a practical representative of DeSci. This is something several protocols in the industry are currently working on, but due to the uncertainties and high failure rates of scientific research, implementation should be quite challenging.
The market needs to see a significant number of DeSci instances having an impact in reality to build consensus. This process will take more time than the AI narrative; ChatGPT was released at the end of 2022, and speculation in the crypto circle began in 2023, while DeSci will require a longer time. However, from another perspective, this also paves some stumbling blocks for DeSci, as the rapid development of AI has subconsciously prepared people to accept the possibility of seemingly impossible things becoming reality. The longevity science of VitaDAO is no longer a castle in the air. Overall, I believe the consensus around DeSci has just begun and requires long-term construction, and one should be prepared for this narrative to explode in the next bull market.
About BlockBooster: BlockBooster is an Asian Web3 venture studio supported by OKX Ventures and other top institutions, dedicated to being a trusted partner for outstanding entrepreneurs. We connect Web3 projects with the real world through strategic investments and deep incubation, helping quality entrepreneurial projects grow.
Disclaimer: This article/blog is for reference only, representing the author's personal views and does not reflect the position of BlockBooster. This article does not intend to provide: (i) investment advice or recommendations; (ii) offers or solicitations to buy, sell, or hold digital assets; or (iii) financial, accounting, legal, or tax advice. Holding digital assets, including stablecoins and NFTs, carries high risks, significant price volatility, and may even become worthless. You should carefully consider whether trading or holding digital assets is suitable for you based on your financial situation. For specific issues, please consult your legal, tax, or investment advisor. The information provided in this article (including market data and statistics, if any) is for general reference only. Reasonable care has been taken in compiling this data and charts, but no responsibility is accepted for any factual inaccuracies or omissions expressed therein.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
HSBC: Still expects the Fed to cut interest rates by 75 basis points in 2025
AAVE breaks above $320
BTC breaks through $95,000
Animoca Co-Creation: Will airdrop its own MOCA to the community in two phases